* Oxigene announces results of Phase 2 study of CA4P in
recurrent ovarian cancer published in journal of clinical
oncology
The post BRIEF-Oxigene says Phase 2 study of CA4P met primary endpoint of improvement appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Oxigene announces results of Phase 2 study of CA4P in
recurrent ovarian cancer published in journal of clinical
oncology
The post BRIEF-Oxigene says Phase 2 study of CA4P met primary endpoint of improvement appeared first on NASDAQ.